Research Overview
Retatrutide is a triple receptor agonist targeting GIP, GLP-1, and glucagon receptors simultaneously. It represents the frontier of incretin-based metabolic research. In vitro applications include triple receptor pharmacology, comparative agonist studies, energy expenditure pathway research, and multi-receptor signaling analysis.
Compound Specifications
| Molecular Formula | C₂₂₈H₃₅₄N₄₈O₆₈ |
|---|---|
| Molecular Weight | ~4,900 Da |
| CAS Number | 2381089-83-2 |
| Sequence | Triple agonist peptide sequence — GIP/GLP-1/Glucagon receptor targeting |
| Purity | >98% (HPLC verified) |
| Storage | Store at -20°C. Stable 24 months lyophilized. |
| Form | Lyophilized powder |
⚠ GLP-1 COMPOUND — ENHANCED COMPLIANCE NOTICE
This compound is a GLP-1 receptor agonist analog. It is subject to heightened regulatory scrutiny. Purchase is restricted to verified research institutions and qualified researchers. This compound is NOT approved for human use and is sold exclusively for in vitro laboratory research. Misuse or diversion for human administration is strictly prohibited and may be unlawful.
This compound is a GLP-1 receptor agonist analog. It is subject to heightened regulatory scrutiny. Purchase is restricted to verified research institutions and qualified researchers. This compound is NOT approved for human use and is sold exclusively for in vitro laboratory research. Misuse or diversion for human administration is strictly prohibited and may be unlawful.
Certificate of Analysis
Each batch is third-party tested. COA available upon request — contact us with your order number.
⚠ RESEARCH USE ONLY — This product is sold exclusively for in vitro laboratory research purposes. It is not intended for human or veterinary use, consumption, injection, or any clinical application. Not for sale to minors. By purchasing, you confirm you are a qualified research professional aged 21 or older.
Reviews
There are no reviews yet.